| Gout, Hyperuricemia, Uric Acid | Lifetime | 12 | US 8 | 99.25 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 70 | US 28 | 99.60 |
| Case Reports on Hematomas | Lifetime | 9 | US 7 | 99.13 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 44 | US 22 | 99.28 |
| Lower Extremity Biomechanics and Pathologies | Lifetime | 111 | US 51 | 99.02 |
| Urticaria and Related Conditions | Lifetime | 137 | US 54 | 98.55 |
| Musculoskeletal pain and rehabilitation | Lifetime | 403 | US 150 | 98.71 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 244 | US 71 | 98.99 |
| Bone and Joint Diseases | Lifetime | 200 | US 78 | 98.25 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 182 | US 77 | 98.02 |
| Inflammatory mediators and NSAID effects | Lifetime | 344 | US 168 | 97.86 |
| Pain Mechanisms and Treatments | Lifetime | 381 | US 163 | 98.26 |
| Spondyloarthritis Studies and Treatments | Lifetime | 261 | US 54 | 97.37 |
| Total Knee Arthroplasty Outcomes | Lifetime | 722 | US 349 | 97.82 |
| Alcohol Consumption and Health Effects | Lifetime | 866 | US 402 | 94.77 |
| Knee injuries and reconstruction techniques | Lifetime | 972 | US 427 | 95.92 |
| Vitamin K Research Studies | Lifetime | 321 | US 139 | 91.61 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 22 | US 3 | 99.07 |
| Pain Mechanisms and Treatments | 2021-2025 | 30 | US 10 | 98.48 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 22 | US 5 | 95.69 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 246 | US 61 | 96.92 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 42 | US 12 | 94.44 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 147 | US 37 | 93.40 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 295 | US 49 | 95.43 |
| Lower Extremity Biomechanics and Pathologies | 2021-2025 | 295 | US 75 | 92.39 |
| Case Reports on Hematomas | 2021-2025 | 21 | US 12 | 89.90 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 312 | US 49 | 91.00 |
| Total Knee Arthroplasty Outcomes | 2021-2025 | 896 | US 344 | 91.91 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 180 | US 36 | 82.33 |
| Pharmacology and Obesity Treatment | 2021-2025 | 384 | US 171 | 75.82 |
| Alkaline Phosphatase Research Studies | 2021-2025 | 248 | US 45 | 34.72 |
